A Prospective, Open Label, Randomized, Comparative Study of Ramipril 5mg Plus Felodipine 5mg Combined Regimen and Ramipril 10mg in Uncontrolled Hypertensive Patients.
Phase of Trial: Phase IV
Latest Information Update: 09 Dec 2009
At a glance
- Drugs Felodipine/ramipril; Ramipril
- Indications Essential hypertension
- Focus Therapeutic Use
- Sponsors Sanofi
- 07 Nov 2009 Actual end date (Sep 2009) added as reported by ClinicalTrials.gov.
- 07 Nov 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Aug 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.